Cargando…
Surgery and Medical Treatment in Microprolactinoma: A Systematic Review and Meta-Analysis
OBJECTIVE: Dopamine agonists (DAs) are recommended as the first-line treatment for prolactinomas; however, tumour recurrence after drug withdrawal remains a clinical problem. Recent studies have reported high remission rates via surgery in microprolactinomas. The aim of this systematic review and me...
Autores principales: | Lu, Jianglong, Cai, Lin, Wu, Zerui, Lin, Weiwei, Xu, Jiadong, Zhu, Zhangzhang, Wang, Chengde, Li, Qun, Su, Zhipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423556/ https://www.ncbi.nlm.nih.gov/pubmed/34504526 http://dx.doi.org/10.1155/2021/9930059 |
Ejemplares similares
-
Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas
por: Wu, Zerui, et al.
Publicado: (2021) -
A Quantified Risk-Scoring System for the Recurrence of Meningiomas: Results From a Retrospective Study of 392 Patients
por: Zhu, Zhangzhang, et al.
Publicado: (2020) -
A Multielement Prognostic Nomogram Based on a Peripheral Blood Test, Conventional MRI and Clinical Factors for Glioblastoma
por: Rao, Changjun, et al.
Publicado: (2022) -
Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women
por: Chen, Juan, et al.
Publicado: (2022) -
Microprolactinoma with visual field defect: An unsuspected etiology
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)